Markets

Cytokinetics (CYTK) Worth Watching: Stock Surges 10.3%

Cytokinetics, IncorporatedCYTK was a big mover last session, as the company saw its shares rise over 10% on the day. The upside was driven after the company reported third-quarter net income of $31.9 million on Oct 27. The news also led to far more shares changing hands than in a normal session, resulting in solid volume. This reverses the recent trend of the company, as the stock is now trading above the volatile price range of $8.83 to $9.65 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days, while the Zacks Consensus Estimate also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cytokinetics carries a Zacks Rank #2 (Buy).

CYTOKINETCS INC Price

CYTOKINETCS INC Price | CYTOKINETCS INC Quote

Another favorably-ranked stock in the same industry is Adocia S.A. ADOCY , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Is CYTK going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

CYTOKINETCS INC (CYTK): Free Stock Analysis Report

ADOCIA (ADOCY): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CYTK

Other Topics

Investing Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More